Day 1: Saturday, 22 October 2022
| 07:50 – 08:50 | Registration and Refreshments | |
| 08:50 – 09:00 | Opening Remarks | |
| Session 1: Inflammatory Arthritis | ||
| 09:00 – 09:50 | EULAR Recommendations for the Management of Rheumatoid Arthritis (RA) with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: 2022 Update | Christopher Edwards |
| 09:50 – 10:00 | Q&A | |
| 10:00 – 10:50 | Innovation Over the Last 5 Years in Inflammatory Joints Diseases: Implications for Future Clinical Practice |
João Eurico Fonseca |
| 10:50 – 11:00 | Q&A | |
| 11:00 – 11:20 | ADARRCTM Refreshment Break & Networking (ARBN) | |
| 11:20 – 12:05 | Going Beyond; A Focus on Baricitinib’s Evidence in the Management of Rheumatoid Arthritis (RA) Industry Symposium by Lilly |
Christopher Edwards |
| 12:05 – 12:50 | Treat to Target Strategy for Management of Systemic Lupus Erythematosus (SLE) Industry Symposium by AstraZeneca |
Eric Morand |
| 12:50 – 14:00 | Lunch | |
| Session 2: Innovation in Rheumatology & Immunology | ||
| 14:00 – 14:50 | Cellular Therapy and Engineering Applied to Rheumatological Diseases | Januario Castro |
| 14:50 – 15:00 | Q&A | |
| 15:00 – 15:50 | Interferon in Systemic Lupus Erythematosus (SLE): From Biology to Therapy | Eric Morand |
| 15:50 – 16:00 | Q&A | |
| 16:00 – 16:45 | Secukinumab for the Axial Spondyloarthritis (axSpA) Spectrum: One Biologic for Non-Radiographic Axial Spondyloarthritis (axSpA) and Ankylosing Spondylitis (AS) Industry Symposium by Novartis |
Zaki Abou Zahr |
| 16:45 – 17:00 | ADARRCTM Refreshment Break & Networking (ARBN) | |
| Parallel Workshops | ||
| 17:00 – 18:00 | Workshop 1: Pain Management in Rheumatoid Arthritis (RA) | Christopher Edwards |
| 17:00 – 18:00 | Workshop 2: Difficult Cases in Rheumatoid Arthritis (RA) | João Eurico Fonseca |
| 17:00 – 18:00 | Workshop 3: Immune System Reconstitution Using Induced Pluripotent Stem Cells – iPSCs | Januario Castro |
| 17:00 – 18:00 | Workshop 4: Lupus Nephritis in the Era of Biologix | Eric Morand |
| END OF DAY 1 | ||
Day 2: Sunday, 23 October 2022
| 07:50 – 08:50 | Registration and Refreshments | |
| 08:50 – 09:00 | Opening Remarks | |
| Session 3: Pediatric Rheumatology & Rare Diseases | ||
| 09:00 – 09:50 | Immunomodulatory Therapy in Multisystem Inflammatory Syndrome in Children (MIS-C) | A.V. Ramanan |
| 09:50 – 10:00 | Q&A | |
| 10:00 – 10:50 | X-Linked Hypophosphatemia (XLH): New Insights | Gavin Clunie |
| 10:50 – 11:00 | Q&A | |
| 11:00 – 11:20 | ADARRCTM Refreshment Break & Networking (ARBN) | |
| 11:20 – 12:05 | Going Beyond; A Focus on Baricitinib’s Evidence in the Management of Rheumatoid Arthritis (RA) Industry Symposium by Lilly |
Osama Haji |
| 12:05 – 12:50 | Beyond COVID-19 Vaccination, Tixagevimab and Cilgevimab Long Acting Monoclonal Antibody Combination for the Preexposure Prophylaxis Against COVID-19 in High Risk Patients Industry Symposium by AstraZeneca |
Suad Hannawi |
| 12:50 – 14:00 | Lunch | |
| Session 4: Connective Tissue Disorders (CTD’s) | ||
| 14:00 – 14:50 | 2022 Update on Antiphospholipid Syndrome (APS): Diagnosis and Treatments | Pier Luigi Meroni |
| 14:50 – 15:00 | Q&A | |
| 15:00 – 15:50 | Can Rheumatoid Arthritis (RA) be Prevented? New Studies | Johannes W.J. Bijlsma |
| 15:50 – 16:00 | Q&A | |
| 16:00 – 16:20 | 12 Years of ADARRCTM | |
| 16:20 – 16:40 | ADARRCTM Refreshment Break & Poster Viewing Session | |
| Parallel Workshops | ||
| 16:40 – 17:40 | Workshop 1: Chronic Recurrent Multifocal Osteomyelitis (CRMO) | A.V. Ramanan |
| 16:40 – 17:40 | Workshop 2: Diagnostic and Therapeutic Spinal Intervention: Role of a Musculoskeletal Radiologist | Raj Chari |
| 16:40 – 17:40 | Workshop 3: Difficult to Treat Rheumatoid Arthritis (RA) | Johannes W.J. Bijlsma |
| 16:40 – 17:40 | Workshop 4: New Oral Anticoagulants Versus Vitamin K Antagonists or Heparin in Antiphospholipid Syndrome (APS) | Pier Luigi Meroni |
| 16:40 – 17:40 | Workshop 5: DXA Scanning: Use and Abuse | Gavin Clunie |
| 16:40 – 18:40 | Workshop 6: Joints and Soft Tissue Injections – Hands-on Practice | Shazia Abdullah Afra Al Dhaheri |
| END OF DAY 2 | ||